Cargando…

Compatibility of aztreonam in four commercial peritoneal dialysis fluids

The preferable route for treatment of peritoneal dialysis related peritonitis remains the intraperitoneal administration of antibiotics admixed to peritoneal dialysis fluids. It is important to know whether the administered drug is compatible with the PD fluids and its container. In the present stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Tobudic, Selma, Prager, Isabella, Kussmann, Manuel, Obermüller, Markus, Ursli, Martin, Zeitlinger, Markus, Wiesholzer, Martin, Burgmann, Heinz, Poeppl, Wolfgang, Reznicek, Gottfried
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000415/
https://www.ncbi.nlm.nih.gov/pubmed/32019947
http://dx.doi.org/10.1038/s41598-020-58391-y
_version_ 1783494037693530112
author Tobudic, Selma
Prager, Isabella
Kussmann, Manuel
Obermüller, Markus
Ursli, Martin
Zeitlinger, Markus
Wiesholzer, Martin
Burgmann, Heinz
Poeppl, Wolfgang
Reznicek, Gottfried
author_facet Tobudic, Selma
Prager, Isabella
Kussmann, Manuel
Obermüller, Markus
Ursli, Martin
Zeitlinger, Markus
Wiesholzer, Martin
Burgmann, Heinz
Poeppl, Wolfgang
Reznicek, Gottfried
author_sort Tobudic, Selma
collection PubMed
description The preferable route for treatment of peritoneal dialysis related peritonitis remains the intraperitoneal administration of antibiotics admixed to peritoneal dialysis fluids. It is important to know whether the administered drug is compatible with the PD fluids and its container. In the present study the compatibility of aztreonam with four commercial PDFs at storing temperatures and duration representative for storing conditions in the clinical settings was investigated. Aztreonam concentrations were determined using high-performance liquid chromatography. The antimicrobial activity of aztreonam was evaluated using an E. coli diffusion disk inhibition assay and P. aeruginosa time-kill curves. In Extraneal evaluated at 6 °C, 25 °C and 37 °C aztreonam was stable over the whole study period of 14 days and 24 hours, respectively. In Physioneal and Nutrineal aztreonam was stable at 6 °C for up to 14 days. Antimicrobial activity was retained in all PD fluids over the whole study period. Aztreonam remained stable and was compatible with the PD fluids, particularly with Extraneal or Nutrineal, and no compensatory dose adjustment is needed when stored for up to 14 days at refrigeration temperature before use.
format Online
Article
Text
id pubmed-7000415
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-70004152020-02-11 Compatibility of aztreonam in four commercial peritoneal dialysis fluids Tobudic, Selma Prager, Isabella Kussmann, Manuel Obermüller, Markus Ursli, Martin Zeitlinger, Markus Wiesholzer, Martin Burgmann, Heinz Poeppl, Wolfgang Reznicek, Gottfried Sci Rep Article The preferable route for treatment of peritoneal dialysis related peritonitis remains the intraperitoneal administration of antibiotics admixed to peritoneal dialysis fluids. It is important to know whether the administered drug is compatible with the PD fluids and its container. In the present study the compatibility of aztreonam with four commercial PDFs at storing temperatures and duration representative for storing conditions in the clinical settings was investigated. Aztreonam concentrations were determined using high-performance liquid chromatography. The antimicrobial activity of aztreonam was evaluated using an E. coli diffusion disk inhibition assay and P. aeruginosa time-kill curves. In Extraneal evaluated at 6 °C, 25 °C and 37 °C aztreonam was stable over the whole study period of 14 days and 24 hours, respectively. In Physioneal and Nutrineal aztreonam was stable at 6 °C for up to 14 days. Antimicrobial activity was retained in all PD fluids over the whole study period. Aztreonam remained stable and was compatible with the PD fluids, particularly with Extraneal or Nutrineal, and no compensatory dose adjustment is needed when stored for up to 14 days at refrigeration temperature before use. Nature Publishing Group UK 2020-02-04 /pmc/articles/PMC7000415/ /pubmed/32019947 http://dx.doi.org/10.1038/s41598-020-58391-y Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Tobudic, Selma
Prager, Isabella
Kussmann, Manuel
Obermüller, Markus
Ursli, Martin
Zeitlinger, Markus
Wiesholzer, Martin
Burgmann, Heinz
Poeppl, Wolfgang
Reznicek, Gottfried
Compatibility of aztreonam in four commercial peritoneal dialysis fluids
title Compatibility of aztreonam in four commercial peritoneal dialysis fluids
title_full Compatibility of aztreonam in four commercial peritoneal dialysis fluids
title_fullStr Compatibility of aztreonam in four commercial peritoneal dialysis fluids
title_full_unstemmed Compatibility of aztreonam in four commercial peritoneal dialysis fluids
title_short Compatibility of aztreonam in four commercial peritoneal dialysis fluids
title_sort compatibility of aztreonam in four commercial peritoneal dialysis fluids
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000415/
https://www.ncbi.nlm.nih.gov/pubmed/32019947
http://dx.doi.org/10.1038/s41598-020-58391-y
work_keys_str_mv AT tobudicselma compatibilityofaztreonaminfourcommercialperitonealdialysisfluids
AT pragerisabella compatibilityofaztreonaminfourcommercialperitonealdialysisfluids
AT kussmannmanuel compatibilityofaztreonaminfourcommercialperitonealdialysisfluids
AT obermullermarkus compatibilityofaztreonaminfourcommercialperitonealdialysisfluids
AT urslimartin compatibilityofaztreonaminfourcommercialperitonealdialysisfluids
AT zeitlingermarkus compatibilityofaztreonaminfourcommercialperitonealdialysisfluids
AT wiesholzermartin compatibilityofaztreonaminfourcommercialperitonealdialysisfluids
AT burgmannheinz compatibilityofaztreonaminfourcommercialperitonealdialysisfluids
AT poepplwolfgang compatibilityofaztreonaminfourcommercialperitonealdialysisfluids
AT reznicekgottfried compatibilityofaztreonaminfourcommercialperitonealdialysisfluids